P-231 - A phase 1/2 study of metronomic 5-fluorouracil (5-FU) plus nab-paclitaxel, bevacizumab, leucovorin, and oxaliplatin (FABLOx) in patients with metastatic pancreatic cancer

Autor: Picozzi, Vincent, Sahai, Vaibhav, Simeone, Diane, Rocha Lima, Caio, Ocean, Allyson, Philip, Philip, Saif, Wasif, Kalyan, Aparna, Ondovik, Michael, Shiansong Li, Jack, Louis, Chrystal
Zdroj: In Annals of Oncology June 2017 28 Supplement 3:iii81-iii82
Databáze: ScienceDirect